Retinal vein occlusion (RVO)

Retinal vein occlusion (RVO) occurs when the flow of blood from the retina is blocked and it is often caused by a blot clot blocking the retinal vein. The area that is not getting enough blood becomes then damaged.

Showing all 2 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PIGF
,
VEGF-A
Fusion protein
Eylea®
40 mg/mL
0,8 mg
-80°C
11/2021
548,10 
view product
Max: 1
Min: 1
Step: 1
PIGF
,
VEGF-A
Fusion protein
Eylea®
40 mg/mL
0,8 mg
-80°C
02/2025
1.011,00 
view product
Max: 1
Min: 1
Step: 1

Not looking for Retinal vein occlusion (RVO)?

Search our therapeutic molecules product database